DE60108164D1 - Cholesterin senkende benzo[b] thiophene und benzo[d]isothiazole - Google Patents

Cholesterin senkende benzo[b] thiophene und benzo[d]isothiazole

Info

Publication number
DE60108164D1
DE60108164D1 DE60108164T DE60108164T DE60108164D1 DE 60108164 D1 DE60108164 D1 DE 60108164D1 DE 60108164 T DE60108164 T DE 60108164T DE 60108164 T DE60108164 T DE 60108164T DE 60108164 D1 DE60108164 D1 DE 60108164D1
Authority
DE
Germany
Prior art keywords
benzo
cholesterin
isothiazole
thiophene
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60108164T
Other languages
English (en)
Other versions
DE60108164T2 (de
Inventor
Johannes Aebi
Jean Ackermann
Henrietta Dehmlow
Hans-Peter Maerki
Olivier Morand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE60108164D1 publication Critical patent/DE60108164D1/de
Application granted granted Critical
Publication of DE60108164T2 publication Critical patent/DE60108164T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
DE60108164T 2000-11-02 2001-10-26 Cholesterin senkende Benzo[b]thiophene und Benzo[d]isothiazole Expired - Lifetime DE60108164T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00123826 2000-11-02
EP00123826 2000-11-02
PCT/EP2001/012451 WO2002036584A1 (en) 2000-11-02 2001-10-26 Cholesterol lowering benzo`b! thiophenes and benzo`d! isothiazoles

Publications (2)

Publication Number Publication Date
DE60108164D1 true DE60108164D1 (de) 2005-02-03
DE60108164T2 DE60108164T2 (de) 2006-03-02

Family

ID=8170270

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60108164T Expired - Lifetime DE60108164T2 (de) 2000-11-02 2001-10-26 Cholesterin senkende Benzo[b]thiophene und Benzo[d]isothiazole

Country Status (21)

Country Link
US (3) US6951879B2 (de)
EP (1) EP1334094B1 (de)
JP (1) JP4012064B2 (de)
KR (1) KR100545430B1 (de)
CN (1) CN1261429C (de)
AR (1) AR034271A1 (de)
AT (1) ATE286042T1 (de)
AU (2) AU1402902A (de)
BR (1) BR0115075A (de)
CA (1) CA2426009C (de)
DE (1) DE60108164T2 (de)
DK (1) DK1334094T3 (de)
ES (1) ES2233703T3 (de)
GT (1) GT200100220A (de)
MX (1) MXPA03003845A (de)
PA (1) PA8531601A1 (de)
PE (1) PE20020600A1 (de)
PT (1) PT1334094E (de)
UY (1) UY27009A1 (de)
WO (1) WO2002036584A1 (de)
ZA (1) ZA200302742B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60135230D1 (de) 2000-08-16 2008-09-18 Hoffmann La Roche Aminocyclohexan-derivate
US7012077B2 (en) * 2001-12-20 2006-03-14 Hoffmann-La Roche Inc. Substituted cyclohexane derivatives
EP1647549A1 (de) * 2004-10-14 2006-04-19 Laboratoire Theramex Indazole, Benzisoxazole und Benzisothiazole mit oestrogenen Eigenschaften
US7446210B2 (en) * 2004-10-26 2008-11-04 Janssen Pharmaceutica N.V. Factor Xa compounds
EP1902023A4 (de) * 2005-06-30 2009-08-12 Bayer Cropscience Ag Verbessertes verfahren zur herstellung insektizider (disubstituiertes propenyl)phenylalkylsubstituierter heterocyclen
FR2913019A1 (fr) * 2007-02-23 2008-08-29 Cerep Sa Composes heterocycliques comme agents anti-neoplasiques ou inhibiteurs de proliferation cellulaire
AU2008331166B2 (en) * 2007-11-29 2013-10-10 Ranbaxy Laboratories Limited Process for the preparation of substituted 1,3-oxathiolanes
WO2009069012A1 (en) * 2007-11-29 2009-06-04 Ranbaxy Laboratories Limited Process and intermediates for the preparation of substituted 1, 3-oxathiolanes, especially lamivudine
CN103596570B (zh) 2010-12-27 2018-02-16 密苏里大学管委会 作为抗癌治疗的蛋白质靶的氧化鲨烯环化酶

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598839A (en) * 1969-06-30 1971-08-10 Parke Davis & Co Phenylbenzothiophene compounds
GR75101B (de) * 1980-10-23 1984-07-13 Pfizer
GB8417559D0 (en) * 1984-07-10 1984-08-15 Pfizer Ltd Anti-diarrhoeal agents
DE3905364A1 (de) 1989-02-22 1990-08-23 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
EP0530149A1 (de) * 1991-08-30 1993-03-03 Ciba-Geigy Ag Schädlingsbekämpfungsmittel
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
CA2190708A1 (en) * 1995-12-08 1997-06-09 Johannes Aebi Aminoalkyl substituted benzo-heterocyclic compounds
CA2190699A1 (en) * 1995-12-08 1997-06-09 Johannes Aebi Tertiary amines
UA56197C2 (uk) 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні

Also Published As

Publication number Publication date
US20050267200A1 (en) 2005-12-01
UY27009A1 (es) 2002-06-20
WO2002036584A1 (en) 2002-05-10
ATE286042T1 (de) 2005-01-15
AU2002214029B2 (en) 2004-12-23
EP1334094A1 (de) 2003-08-13
GT200100220A (es) 2002-07-04
KR20030045166A (ko) 2003-06-09
ZA200302742B (en) 2004-07-08
JP2004513124A (ja) 2004-04-30
CN1471522A (zh) 2004-01-28
AR034271A1 (es) 2004-02-18
ES2233703T3 (es) 2005-06-16
PT1334094E (pt) 2005-05-31
CA2426009C (en) 2008-10-07
US7449483B2 (en) 2008-11-11
PE20020600A1 (es) 2002-07-08
MXPA03003845A (es) 2003-07-28
CA2426009A1 (en) 2002-05-10
BR0115075A (pt) 2003-07-29
DE60108164T2 (de) 2006-03-02
PA8531601A1 (es) 2003-02-14
JP4012064B2 (ja) 2007-11-21
CN1261429C (zh) 2006-06-28
KR100545430B1 (ko) 2006-01-24
US6951879B2 (en) 2005-10-04
EP1334094B1 (de) 2004-12-29
US7173043B2 (en) 2007-02-06
DK1334094T3 (da) 2005-05-02
US20020086891A1 (en) 2002-07-04
AU1402902A (en) 2002-05-15
US20070099985A1 (en) 2007-05-03

Similar Documents

Publication Publication Date Title
DE60125938D1 (de) Selektiv aufweitbarer und lösbarer stent
DE50112013D1 (de) Deodorantien und antiperspirantien
AR028343A1 (es) Derivados de pirrolidina y piperidina
DE60134614D1 (de) Turbinendichtring und entsprechende Turbine
DE69924155D1 (de) Fluoren-copolymere und daraus hergestellte vorrichtungen
DE60111685D1 (de) Antibakterielle und schimmelverhindernde substanzen und antibakterielle und schimmelverhindernde zusammensetzungen
DE60026540D1 (de) Mutilin-derivate und ihre anwendung als antibakterielle mittel
DE69923359D1 (de) Zusammensetzungen und daraus hergestellte gegenstände
DE60138429D1 (de) Schieberegister und elektronisches Gerät
ATE338033T1 (de) Thiophen- und thiazolsulfonamide als antineoplastische mittel
DE60120009D1 (de) Zylinder und Positionsgeber
DK1070059T3 (da) Chromanon- og thiochromanonderivater
DE60003873D1 (de) Resistzusammensetzungen und Strukturierungsverfahren
DE60012333D1 (de) Strickware und strickverfahren
DE60108164D1 (de) Cholesterin senkende benzo[b] thiophene und benzo[d]isothiazole
DE60114850D1 (de) 10-aryl-11h-benzo[b]fluoren-derivate und analoga als östrogene mittel
DE60034754D1 (de) Resistzusammensetzung und Musterübertragungsverfahren
DE50112472D1 (de) Abstreifer und Gutförderer
EE200200135A (et) D4 antagonistidena toimivad tienoisoksasolüül- jatienüülpürrasolüülfenoksü-asendatud propüülderivaadid
AU2489002A (en) Benzofuran and benzothiophene derivatives
DE50112380D1 (de) Drehratensensor und drehratensensorsystem
DE60042893D1 (de) Antibakterieller und biologisch abbaubarer aufgussbehälter
DE60044930D1 (de) Resistzusammensetzung und Musterübertragungsverfahren
DE50100383D1 (de) H-annellierte benzo [f]chromene
DE60120608D1 (de) Behälteranordnung und Behälter

Legal Events

Date Code Title Description
8364 No opposition during term of opposition